How CLM Drives the Sustainable Marketing of Pharma Products

Customer Lifecycle Management (CLM) is a type of marketing concentrated on developing a proper business-customer relationship using the five steps of the customer lifecycle, which are: Reach, Acquire, Develop, Retain, and Advocacy. It describes a transition from user engagement to loyal customer conversion. CLM requires separating active one-time purchasers from loyal customers in several stages of the marketing funnel. The goal here is to maximize customer retention and revenue generation rates.

A Brief Overview of the E-Commerce CLM Strategy 

In terms of scope and functionality, CLM is a relatively slow process that tracks customer interactions, down to the specifics of their purchase history. To clarify, CLM metrics determine factors such as the size of any transaction with the business or the cost of customer acquisition. It’s only possible to develop an effective CLM framework after re-evaluating a company’s ROI success. 

There are many opportunities for businesses to engage with users as they become informed about their products and services. For instance, in the Discovery phase, a merchant can link their e-commerce platform to a frequently-updated blog, accounting for SEO of course. They could also raise post-purchase engagement by installing an automated email system which reaches out to buyers after they check out a shopping cart. 

The Purpose of Customer Lifestyle Management in Pharma Marketing

What about depending on CLM tools to improve the release of commercial pharmaceutical products? The drug manufacturing process could use some budget management, especially when the cost of aging populations and chronic diseases force the pharma industry to churn out new drugs, exhausting their R&D efforts towards innovation.

As a consequence, many pharma companies are revising their marketing plans to put more emphasis on lifecycle management. R&D productivity is falling, and the healthcare market is becoming tighter due to patent restrictions and generic competitors. It doesn’t help that FDA regulations are undercutting methods for extending the shelf life of brands via new dosage combinations. 

Therefore, effective CLM strategies must generate value on existing drugs by advertising their ability to treat a wide range of diseases. This means upgrading their manufacturing lines, developing formulations with fewer side effects, assigning affordable prices to new medications, and distributing products to hospitals and pharmacies overseas.

Leave a Reply